Lipo-C / Lipo-B Injectable BlendWeight LossSafety Rating 7/10

Primary research areaWeight loss adjunct

Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.

Research dose range1–2 mL IM or SC, 1–3x/week. Various formulations (LC120, LC216, LC526, SUPER SHRED LC553) with different concentrations.
AdministrationVaries
Safety7/10 · Components FDA-recognized
NCAA D1Not listed

Price Comparison

Compare vendors

No vendor pricing available for this peptide yet.

Overview

About Lipo-C / Lipo-B Injectable Blend

Mechanism of action

Combination lipotropic injection containing variable mix of: Methionine (amino acid, lipid metabolism), Inositol (cell signaling, fat breakdown), Choline (phospholipid synthesis, liver fat mobilization), B12, L-carnitine, and other co-factors; synergistic hepatic fat mobilization and mitochondrial fat oxidation.

Safety profile

Generally very well-tolerated. Injection site reactions; mild GI effects; urine may develop stronger odor (methionine/choline). Rare hypersensitivity. · B-vitamins, amino acids, carnitine; individual components very safe; compounding quality is main variable

📈

Price tracking starts now.

Set an alert to get notified when this peptide drops.

Related pages

More on Lipo-C / Lipo-B Injectable Blend

Failed to fetch